Skip to main content

Advertisement

SpringerLink
Log in

Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

The real efficacy of selenium supplementation in Hashimoto’s thyroiditis (HT) is still an unresolved issue.

Objectives

We studied the short-term effect of l-selenomethionine on the thyroid function in euthyroid patients with HT. Our primary outcome measures were TSH, thyroid hormones, thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb) levels and thyroid echogenicity after 6 months of l-selenomethionine treatment. The secondary outcome measure was serum CXCL10 levels.

Methods

In a placebo-controlled randomized prospective study, we have enrolled untreated euthyroid patients with HT. Seventy-six patients were randomly assigned to receive l-selenomethionine 166 µg/die (SE n = 38) or placebo (controls n = 38) for 6 months. TSH, free T4 (FT4), free T3 (FT3), TPOAb and CXCL10 serum levels were assayed at time 0, after 3 and 6 months. An ultrasound examination of the left and right thyroid lobe in transverse and longitudinal sections was performed. A rectangular region, the region of interest, was selected for analysis.

Results

TSH, FT4, FT3, TPOAb, thyroid echogenicity and CXCL10 were not statistically different between SE and control groups at time 0, after 3 and 6 months. In the SE group, FT4 levels were significantly decreased (P < 0.03) after 3 months, while FT3 increased (P < 0.04) after 3 and 6 months versus baseline values. In the control group, the FT3 decreased after 3 and 6 months (P < 0.02) compared to baseline.

Conclusion

The short-term l-selenomethionine supplementation has a limited impact on the natural course in euthyroid HT. Our results tip the balance toward the ineffectiveness of short-term l-selenomethionine supplementation in HT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Almandoz J, Gharib H (2012) Hypothyroidism: etiology, diagnosis, and management. Med Clin N Am 96:203–221

    Article  CAS  PubMed  Google Scholar 

  2. Renzullo A, Accardo G, Esposito D, De Bellis A, Bizzarro A, Romano M, Federico A, Gravina AG, Conzo G, Pannone G, Faggiano A, Colao A, Pasquali D (2013) Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. Eur J Inflamm 11:863–870

    CAS  Google Scholar 

  3. Wiebolt J, Achterbergh R, den Boer A, van der Leij S, Marsch E, Suelmann B, de Vries R, van Haeften TW (2011) Clustering of additional autoimmunity behaves differently in Hashimoto’s patients compared with Graves’ patients. Eur J Endocrinol 164:789–794

    Article  CAS  PubMed  Google Scholar 

  4. Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S (2013) Hashimoto’s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23:142–150

    Article  PubMed  PubMed Central  Google Scholar 

  5. Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P (2014) Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev 13:272–280

    Article  CAS  PubMed  Google Scholar 

  6. Rotondi M, Coperchini F, Pignatti P, Sideri R, Groppelli G, Leporati P, La Manna L, Magri F, Mariotti S, Chiovato L (2013) Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation? J Clin Endocrinol Metab 98:308–313

    Article  CAS  PubMed  Google Scholar 

  7. Effraimidis G, Strieder TG, Tijssen JG, Wiersinga WM (2011) Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol 164:107–113

    Article  CAS  PubMed  Google Scholar 

  8. Drutel A, Archambeaud F, Caron P (2013) Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol (Oxf) 78:155–164

    Article  CAS  Google Scholar 

  9. Gärtner R, Gasnier BC (2003) Selenium in the treatment of autoimmune thyroiditis. BioFactors 19:165–170

    Article  PubMed  Google Scholar 

  10. Turker O, Kumanlioglu K, Karapolat I, Dogan I (2006) Selenium treatment in autoimmune thyroiditis: 9 month follow-up with variable doses. J Endocrinol 190:151–156

    Article  CAS  PubMed  Google Scholar 

  11. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92:1263–1268

    Article  CAS  PubMed  Google Scholar 

  12. Nacamulli D, Mian C, Petricca D, Lazzarotto F, Barollo S, Pozza D, Masiero S, Faggian D, Plebani M, Girelli ME, Mantero F, Betterle C (2010) Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol (Oxf) 73:535–539

    CAS  Google Scholar 

  13. Krysiak R, Okopien B (2011) The effect of levo-thyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 96:2206–2215

    Article  CAS  PubMed  Google Scholar 

  14. Krysiak R, Okopien B (2012) Haemostatic effects of levo-thyroxine and selenomethionine in euthyroid patients with Hashimoto’s thyroiditis. Thromb Haemost 108:973–980

    Article  CAS  PubMed  Google Scholar 

  15. Petricca D, Nacamulli D, Mian C, Mantero F, Cavedon E, Girelli ME, Betterle C (2012) Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review. J Endocrinol Investig 35:419–424

    CAS  Google Scholar 

  16. Köhrle J (2015) Selenium and the thyroid. Curr Opin Endocrinol Diabetes Obes 22:392–401

    Article  PubMed  Google Scholar 

  17. van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H (2013) Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst Rev 6:D010223

    Google Scholar 

  18. Koprowski R, Korzyńska A, Wróbel Z, Zieleźnik W, Witkowska A, Małyszek J, Wójcik W (2012) Influence of the measurement method of features in ultrasound images of the thyroid in the diagnosis of Hashimoto’s disease. Biomed Eng Online 11:91

    Article  PubMed  PubMed Central  Google Scholar 

  19. De Fusco C, Nettore IC, Colao A, Macchia P (2013) Selenium in the thyroid: physiology and pathology. Rev Endocrinol Metab CIC Edizioni Int 1:34–40

    Google Scholar 

  20. Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241

    Article  CAS  PubMed  Google Scholar 

  21. Rayman MP (2012) Selenium and human health. Lancet 379:1256–1268

    Article  CAS  PubMed  Google Scholar 

  22. Wu Q, Rayman MP, Lv H (2015) Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 100:4037–4047

    Article  CAS  PubMed  Google Scholar 

  23. Panicker V (2011) Genetics of thyroid function and disease. Clin Biochem Rev 32:165–175

    PubMed  PubMed Central  Google Scholar 

  24. Olivieri O, Girelli D, Azzini M, Stanzial AM, Russo C, Ferroni M, Corrocher R (1995) Low selenium status in the elderly influences thyroid hormones. Clin Sci 89:637–642

    Article  CAS  PubMed  Google Scholar 

  25. Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87:1687–1691

    Article  PubMed  Google Scholar 

  26. Bratakos MS, Kanaki HC, Vasiliou-Waite A, Ioannou PV (1990) The nutritional selenium status of healthy Greeks. Sci Total Environ 91:161–176

    Article  CAS  PubMed  Google Scholar 

  27. Duntas LH, Mantzou E, Koutras DA (2003) Effects of a 6 month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148:389–393

    Article  CAS  PubMed  Google Scholar 

  28. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES (2007) Effects of 12 months treatment with l-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid 17:609–612

    Article  CAS  PubMed  Google Scholar 

  29. de Farias CR, Cardoso BR, de Oliveira GM, de Mello Guazzelli IC, Catarino RM, Chammas MC, Cozzolino SM, Knobel M (2015) A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J Endocrinol Invest 38:1065–1074

    Article  PubMed  Google Scholar 

  30. Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D (2010) Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 20:1163–1173

    Article  CAS  PubMed  Google Scholar 

  31. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves’ Orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur Thyroid J 5:9–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pilli T, Cantara S, Schomburg L, Cenci V, Cardinale S, Heid EC, Kühn EC, Cevenini G, Sestini F, Fioravanti C, D’Hauw G, Pacini F (2015) IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: comparison between two doses of selenomethionine (80 or 160 μg) versus Placebo. Eur Thyroid J 4:226–233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Fallahi P, Ferrari SM, Elia G, Nasini F, Colaci M, Giuggioli D, Vita R, Benvenga S, Ferri C, Antonelli A (2016) Novel therapies for thyroid autoimmune diseases. Expert Rev Clin Pharmacol 9:853–861

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Piazza Miraglia n 2, 80100, Naples, Italy

    D. Esposito, G. Accardo, G. Docimo, F. Selvaggi, D. Giugliano & D. Pasquali

  2. Unit of Internal Medicine and Endocrinology, Fondazione Salvatore Maugeri IRCCS, University of Pavia, Pavia, Italy

    M. Rotondi & L. Chiovato

  3. Department of Pediatric Radiology, University Hospital Federico II, Naples, Italy

    G. Vallone

  4. Division of General and Oncologic Surgery, Department of Anesthesiology, Surgical and Emergency Sciences, Second University of Naples, Naples, Italy

    G. Conzo

  5. Endocrine and Metabolic Unit, Department of Medical and Surgical Sciences, Clinica Medica, 2nd Medicina, University of Brescia, Spedali Civili di Brescia, Brescia, Italy

    C. Cappelli

Authors
  1. D. Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Rotondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Accardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Vallone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Conzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Docimo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Selvaggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Cappelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. Chiovato
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D. Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D. Pasquali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Pasquali.

Ethics declarations

Conflict of interest

The authors have nothing to declare.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esposito, D., Rotondi, M., Accardo, G. et al. Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J Endocrinol Invest 40, 83–89 (2017). https://doi.org/10.1007/s40618-016-0535-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-016-0535-4

Keywords

Search

Navigation